Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
CD8A	925	broad.mit.edu	37	2	87013056	87013056	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr2:87013056G>A	ENST00000409511.2	-	9	1725	c.695C>T	c.(694-696)gCg>gTg	p.A232V	CD8A_ENST00000352580.3_Missense_Mutation_p.A195V|CD8A_ENST00000409781.1_Missense_Mutation_p.A195V|CD8A_ENST00000283635.3_Missense_Mutation_p.A232V|CD8A_ENST00000456996.2_Missense_Mutation_p.A195V|CD8A_ENST00000538832.1_Missense_Mutation_p.A273V	NM_001145873.1	NP_001139345.1	P01732	CD8A_HUMAN	CD8a molecule	232		NA		NA	antigen processing and presentation|regulation of immune response|transmembrane receptor protein tyrosine kinase signaling pathway	extracellular region|integral to plasma membrane|T cell receptor complex	coreceptor activity|MHC class I protein binding			lung(4)|ovary(1)|prostate(2)|urinary_tract(1)	8						GACGTATCTCGCCGAAAGGCT	0.507	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						187	182	184	NA		NA	NA	2		NA											NA				87013056		2203	4300	6503	SO:0001583	missense			ENSG00000153563	HGNC:1706	NM_001768	Approved	uc002sru.3	NA	D6W5M8|Q13970|Q4ZG17	ENST00000409511.2	37	CCDS1992.1	.	.	.	.	.	.	.	.	.	.	T	19.66	3.86824	0.72065	.	.	ENSG00000153563	ENST00000456996;ENST00000352580;ENST00000283635;ENST00000409511;ENST00000442577;ENST00000538832;ENST00000409781	T;T;T;T;T;T	0.78481	-1.18;-1.18;-1.08;-1.08;-1.13;-1.09	4.03	2.88	0.33553	.	0.692087	0.15139	N	0.278366	T	0.51398	0.1672	N	0.08118	0	0.09310	N	1	B;B;B	0.31241	0.003;0.002;0.315	B;B;B	0.15870	0.0;0.001;0.014	T	0.43360	-0.9396	10	0.52906	T	0.07	-18.0343	4.2044	0.10481	0.0:0.1065:0.2083:0.6852	.	273;195;232	B4DT80;P01732-2;P01732	.;.;CD8A_HUMAN	V	195;195;232;232;217;273;195	ENSP00000398868:A195V;ENSP00000321631:A195V;ENSP00000283635:A232V;ENSP00000386559:A232V;ENSP00000438371:A273V;ENSP00000387314:A195V	ENSP00000283635:A232V	A	-	2	0	CD8A	86866567	0.046	0.20272	0.007	0.13788	0.003	0.03518	0.277	0.18734	0.373	0.24621	-0.256	0.111	GCG	CD8A-006	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000330784.3	128.836764	KEEP		-	141.115937	0.25	54	162	---	---	---	---	1	1	306	786	6	1483	59	171	0	260	11	TP
DNAH8	1769	broad.mit.edu	37	6	38957817	38957817	+	Silent	SNP	G	G	A	rs143472136	byFrequency	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr6:38957817G>A	ENST00000359357.3	+	86	12686	c.12432G>A	c.(12430-12432)ccG>ccA	p.P4144P	DNAH8_ENST00000441566.1_Silent_p.P4108P					dynein, axonemal, heavy chain 8	NA		NA		NA						NS(7)|breast(9)|central_nervous_system(4)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(3)|kidney(16)|large_intestine(44)|liver(4)|lung(101)|ovary(7)|pancreas(2)|prostate(8)|skin(28)|stomach(4)|upper_aerodigestive_tract(6)|urinary_tract(4)	260						TGTTTGAACCGTCATTCTGCT	0.368	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	G		2,4404	4.2+/-10.8	0,2,2201	155	146	149	NA	13083	-5.6	0.4	6	dbSNP_134	149	1,8599	1.2+/-3.3	0,1,4299	no	coding-synonymous	DNAH8	NM_001206927.1		0,3,6500	AA,AG,GG	NA	0.0116,0.0454,0.0231		4361/4708	38957817	3,13003	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000124721	HGNC:2952	NM_001206927	Approved	uc021yzh.1	NA		ENST00000359357.3	37													NA	NA	NA								NA	NA	NA																													NA	NA															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		DNAH8-001	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000043574.1	254.314604	KEEP		+	261.058411	0.330827	88	178	---	---	---	---	1	1	271	394	0	895	100	217	0	309	2	TP
OPN5	221391	broad.mit.edu	37	6	47763200	47763200	+	Silent	SNP	C	C	T			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr6:47763200C>T	ENST00000489301.2	+	4	742	c.657C>T	c.(655-657)taC>taT	p.Y219Y	OPN5_ENST00000244799.4_3'UTR|OPN5_ENST00000371211.2_Silent_p.Y219Y|OPN5_ENST00000393699.2_Silent_p.Y219Y			Q6U736	OPN5_HUMAN	opsin 5	219		NA		NA	phototransduction|protein-chromophore linkage|visual perception	integral to membrane	G-protein coupled receptor activity|photoreceptor activity			endometrium(1)|large_intestine(3)|lung(14)|ovary(1)|prostate(2)|skin(6)|upper_aerodigestive_tract(2)	29						TGTTCTCCTACGTAAAGATCA	0.512	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Melanoma(28;740 973 10870 42660 45347)					NA		NA		NA		0							NA	C		0,4406		0,0,2203	119	105	109	NA	657	-8.4	0.8	6		109	2,8598	2.2+/-6.3	0,2,4298	no	coding-synonymous	OPN5	NM_181744.3		0,2,6501	TT,TC,CC	NA	0.0233,0.0,0.0154		219/355	47763200	2,13004	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000124818	HGNC:19992	NM_181744	Approved	uc003ozc.3	NA	A0AV33|Q5T5B9|Q5T886|Q7Z603|Q86SL5	ENST00000489301.2	37													NA	NA	NA								NA	NA	NA																													NA	NA															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		OPN5-002	NOVEL	not_organism_supported|basic	protein_coding	NA	protein_coding	OTTHUMT00000040824.2	154.179361	KEEP		+	159.367747	0.320442	58	123	---	---	---	---	1	1	362	679	2	1376	70	140	1	206	6	TP
PKHD1	5314	broad.mit.edu	37	6	51889738	51889738	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr6:51889738G>A	ENST00000371117.3	-	32	5145	c.4870C>T	c.(4870-4872)Cgg>Tgg	p.R1624W	PKHD1_ENST00000340994.4_Missense_Mutation_p.R1624W	NM_138694.3	NP_619639.3	P08F94	PKHD1_HUMAN	polycystic kidney and hepatic disease 1 (autosomal recessive)	1624	IPT/TIG 11.	NA	R -> W (in ARPKD).	NA	cell-cell adhesion|cilium assembly|homeostatic process|kidney development|negative regulation of cellular component movement	anchored to external side of plasma membrane|apical plasma membrane|integral to membrane|microtubule basal body	protein binding|receptor activity	p.R1624W(1)		NS(1)|autonomic_ganglia(1)|breast(8)|central_nervous_system(5)|cervix(1)|endometrium(16)|haematopoietic_and_lymphoid_tissue(4)|kidney(11)|large_intestine(59)|lung(139)|ovary(16)|prostate(8)|skin(20)|soft_tissue(1)|stomach(2)|upper_aerodigestive_tract(7)|urinary_tract(5)	304	Lung NSC(77;0.0605)					ACAATGCACCGGATGAGCTCA	0.507	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Missense(1)	large_intestine(1)	GRCh37	CM020959	PKHD1	M	NA	G	TRP/ARG,TRP/ARG	0,4406		0,0,2203	159	147	151	NA	4870,4870	4.4	0.1	6		151	2,8598	2.2+/-6.3	0,2,4298	yes	missense,missense	PKHD1	NM_138694.3,NM_170724.2	101,101	0,2,6501	AA,AG,GG	NA	0.0233,0.0,0.0154	probably-damaging,probably-damaging	1624/4075,1624/3397	51889738	2,13004	2203	4300	6503	SO:0001583	missense			ENSG00000170927	HGNC:9016	NM_138694	Approved	uc003pah.1	NA	Q5VUA2|Q5VUA3|Q5VWV1|Q8TCZ9	ENST00000371117.3	37	CCDS4935.1	.	.	.	.	.	.	.	.	.	.	G	16.06	3.014766	0.54468	0.0	2.33E-4	ENSG00000170927	ENST00000371117;ENST00000340994;ENST00000393616	T;T	0.77620	-1.11;-1.11	5.3	4.43	0.53597	Cell surface receptor IPT/TIG (2);Immunoglobulin E-set (1);Immunoglobulin-like fold (1);	0.722191	0.13307	N	0.397776	T	0.59851	0.2224	N	0.14661	0.345	0.26605	N	0.972952	P;D	0.63046	0.829;0.992	P;P	0.53549	0.663;0.729	T	0.56854	-0.7910	10	0.38643	T	0.18	.	12.8124	0.57647	0.079:0.0:0.921:0.0	.	1624;1624	P08F94-2;P08F94	.;PKHD1_HUMAN	W	1624	ENSP00000360158:R1624W;ENSP00000341097:R1624W	ENSP00000341097:R1624W	R	-	1	2	PKHD1	51997697	1	0.71417	0.085	0.20634	0.48	0.33159	4.725	0.61979	1.231	0.43661	0.65	0.86243	CGG	PKHD1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000040893.1	334.801363	KEEP		-	338.196477	0.382143	107	173	---	---	---	---	1	1	907	1176	4	2736	118	197	0	341	9	TP
OOEP	441161	broad.mit.edu	37	6	74079390	74079390	+	Silent	SNP	C	C	T			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr6:74079390C>T	ENST00000370359.5	-	1	125	c.126G>A	c.(124-126)ccG>ccA	p.P42P	OOEP-AS1_ENST00000445350.2_RNA|OOEP_ENST00000370363.1_Intron	NM_001080507.2	NP_001073976.1	A6NGQ2	OOEP_HUMAN	oocyte expressed protein	42		NA		NA		cytoplasm				large_intestine(2)|lung(4)|prostate(1)|upper_aerodigestive_tract(1)	8						GTTCCTGCACCGGAAACCACC	0.622	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						78	85	83	NA		NA	NA	6		NA											NA				74079390		2061	4223	6284	SO:0001819	synonymous_variant			ENSG00000203907	HGNC:21382	NM_001080507	Approved	uc003pgu.4	NA	A6NIN5|A9UIB7	ENST00000370359.5	37	CCDS47451.1												NA	NA	NA								NA	NA	NA																													NA	NA															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		OOEP-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000108414.2	116.555551	KEEP		-	124.608398	0.265432	43	119	---	---	---	---	1	1	808	1271	6	2398	66	149	0	244	12	TP
FILIP1	27145	broad.mit.edu	37	6	76024625	76024625	+	Nonsense_Mutation	SNP	G	G	T			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr6:76024625G>T	ENST00000393004.2	-	5	1144	c.923C>A	c.(922-924)tCg>tAg	p.S308*	FILIP1_ENST00000237172.7_Nonsense_Mutation_p.S308*|FILIP1_ENST00000498523.1_5'UTR|FILIP1_ENST00000370020.1_Nonsense_Mutation_p.S209*			Q7Z7B0	FLIP1_HUMAN	filamin A interacting protein 1	308		NA		NA						breast(3)|central_nervous_system(3)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(18)|liver(1)|lung(28)|ovary(1)|pancreas(1)|prostate(5)|skin(9)|upper_aerodigestive_tract(4)	80						AGAAAACCTCGAAGCCTTGTG	0.423	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						149	136	141	NA		NA	NA	6		NA											NA				76024625		2203	4300	6503	SO:0001587	stop_gained			ENSG00000118407	HGNC:21015	XM_029179	Approved	uc003pia.3	NA	B2RMU6|Q5VUL6|Q86TC3|Q8N8B9|Q96SK6|Q9NVI8|Q9ULE5	ENST00000393004.2	37		.	.	.	.	.	.	.	.	.	.	G	37	6.320088	0.97471	.	.	ENSG00000118407	ENST00000393004;ENST00000237172;ENST00000370020	.	.	.	5.71	5.71	0.89125	.	0.064305	0.64402	D	0.000004	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	-9.6148	20.2245	0.98337	0.0:0.0:1.0:0.0	.	.	.	.	X	308;308;209	.	ENSP00000237172:S308X	S	-	2	0	FILIP1	76081345	0.909	0.30893	0.965	0.4072	0.695	0.4033	2.59	0.46154	2.861	0.98227	0.65	0.86243	TCG	FILIP1-004	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000471226.1	179.635273	KEEP		-	183.224097	0.35	63	117	---	---	---	---	1	1	388	575	1	1209	66	134	1	214	9	TP
SEC63	11231	broad.mit.edu	37	6	108225906	108225906	+	Missense_Mutation	SNP	T	T	G			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr6:108225906T>G	ENST00000369002.4	-	11	1160	c.981A>C	c.(979-981)aaA>aaC	p.K327N		NM_007214.4	NP_009145.1	Q9UGP8	SEC63_HUMAN	SEC63 homolog (S. cerevisiae)	327	SEC63 1.	NA		NA	protein folding|protein targeting to membrane	endoplasmic reticulum membrane|integral to membrane	heat shock protein binding|receptor activity|unfolded protein binding			endometrium(3)|kidney(4)|large_intestine(7)|lung(14)|ovary(3)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	36		all_cancers(87;5.35e-06)|Acute lymphoblastic leukemia(125;2.66e-08)|all_hematologic(75;1.13e-06)|all_epithelial(87;0.00225)|Colorectal(196;0.0294)		BRCA - Breast invasive adenocarcinoma(108;0.0079)|Epithelial(106;0.0356)|all cancers(137;0.0525)|OV - Ovarian serous cystadenocarcinoma(136;0.054)		CAGGACACTTTTTTAGCATGA	0.348	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						125	128	127	NA		NA	NA	6		NA											NA				108225906		2203	4300	6503	SO:0001583	missense			ENSG00000025796	HGNC:21082	NM_007214	Approved	uc003psc.4	NA	O95380|Q5THN4|Q86VS9|Q8IWL0|Q9NTE0	ENST00000369002.4	37	CCDS5061.1	.	.	.	.	.	.	.	.	.	.	T	17.09	3.299858	0.60195	.	.	ENSG00000025796	ENST00000369002;ENST00000423697	T	0.60920	0.15	5.41	5.41	0.78517	Sec63 domain (3);	0.042071	0.85682	D	0.000000	T	0.60715	0.2290	M	0.69823	2.125	0.58432	D	0.999996	P;P	0.52577	0.924;0.954	P;P	0.60886	0.88;0.812	T	0.65331	-0.6194	10	0.45353	T	0.12	-21.2434	8.7777	0.34771	0.0:0.1477:0.0:0.8523	.	327;327	Q9UGP8;B3KQF0	SEC63_HUMAN;.	N	327;187	ENSP00000357998:K327N	ENSP00000357998:K327N	K	-	3	2	SEC63	108332599	1	0.71417	1	0.80357	0.643	0.38383	2.384	0.44362	2.048	0.60808	0.477	0.44152	AAA	SEC63-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000041705.4	446.997329	KEEP		-	447.957138	0.438356	128	164	---	---	---	---	1	1	354	460	0	809	146	188	0	272	2	TP
EGFR	1956	broad.mit.edu	37	7	55210075	55210075	+	Missense_Mutation	SNP	T	T	G			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr7:55210075T>G	ENST00000275493.2	+	2	362	c.185T>G	c.(184-186)cTt>cGt	p.L62R	EGFR_ENST00000454757.2_Missense_Mutation_p.L9R|EGFR_ENST00000455089.1_Missense_Mutation_p.L62R|EGFR_ENST00000344576.2_Missense_Mutation_p.L62R|EGFR_ENST00000442591.1_Missense_Mutation_p.L62R|EGFR_ENST00000420316.2_Missense_Mutation_p.L62R|EGFR_ENST00000342916.3_Missense_Mutation_p.L62R	NM_005228.3	NP_005219.2	P00533	EGFR_HUMAN	epidermal growth factor receptor	62		NA		NA	activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity	p.L62R(3)		NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	GAGGTGGTCCTTGGGAATTTG	0.408	NA	8	"""A, O, Mis"""	NA	"""glioma, NSCLC"""	NSCLC	NA	NA	Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Dom	yes	Familial lung cancer	7	7p12.3-p12.1	1956	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""	NA	"""E, O"""	3	Substitution - Missense(3)	lung(2)|central_nervous_system(1)					NA						175	167	170	NA		NA	NA	7		NA											NA				55210075		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	NA	O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	ENST00000275493.2	37	CCDS5514.1	.	.	.	.	.	.	.	.	.	.	T	19.51	3.842145	0.71488	.	.	ENSG00000146648	ENST00000455089;ENST00000342916;ENST00000344576;ENST00000420316;ENST00000275493;ENST00000442591;ENST00000450046;ENST00000454757	T;T;T;T;T;T;T;T	0.79454	-1.27;-1.27;-1.27;-1.27;-1.27;-1.27;-1.27;-1.27	6.05	4.9	0.64082	EGF receptor, L domain (1);	0.059356	0.64402	D	0.000001	D	0.87857	0.6283	M	0.86028	2.79	0.54753	D	0.999982	P;P;D;D;D	0.89917	0.882;0.795;1.0;0.991;0.992	P;P;D;P;P	0.74674	0.626;0.553;0.984;0.825;0.814	D	0.88586	0.3140	10	0.72032	D	0.01	.	11.1407	0.484	0.0:0.0723:0.0:0.9277	.	62;62;62;62;62	Q504U8;P00533;P00533-3;P00533-4;P00533-2	.;EGFR_HUMAN;.;.;.	R	62;62;62;62;62;62;9;9	ENSP00000415559:L62R;ENSP00000342376:L62R;ENSP00000345973:L62R;ENSP00000413843:L62R;ENSP00000275493:L62R;ENSP00000410031:L62R;ENSP00000413354:L9R;ENSP00000395243:L9R	ENSP00000275493:L62R	L	+	2	0	EGFR	55177569	1	0.71417	0.981	0.43875	0.771	0.43674	5.95	0.70265	1.114	0.41781	-0.263	0.10527	CTT	EGFR-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251456.2	-2524.820797	KEEP		+	67.936178	0.005837	53	9027	---	---	---	---	1	0.9430589	6	841	0	1011	44	7976	1	228	2	TP
KEL	3792	broad.mit.edu	37	7	142655026	142655026	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr7:142655026G>T	ENST00000355265.2	-	6	1034	c.560C>A	c.(559-561)tCc>tAc	p.S187Y	KEL_ENST00000479768.2_5'UTR	NM_000420.2	NP_000411.1	P23276	KELL_HUMAN	Kell blood group, metallo-endopeptidase	187		NA		NA	proteolysis|vasoconstriction	integral to membrane|plasma membrane	metal ion binding|metalloendopeptidase activity|protein binding			central_nervous_system(1)|endometrium(3)|kidney(5)|large_intestine(11)|lung(34)|ovary(3)|prostate(2)|skin(1)	60	Melanoma(164;0.059)					AAAGTTTAAGGAAGTCCATTT	0.517	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						94	80	85	NA		NA	NA	7		NA											NA				142655026		2203	4300	6503	SO:0001583	missense			ENSG00000197993	HGNC:6308	NM_000420	Approved	uc003wcb.3	NA	B2RBV4|Q96RS8|Q99885	ENST00000355265.2	37	CCDS34766.1	.	.	.	.	.	.	.	.	.	.	G	12.28	1.891968	0.33442	.	.	ENSG00000197993	ENST00000355265;ENST00000467543	T;T	0.74315	-0.83;-0.83	5.8	2.97	0.34412	Peptidase M13 (1);	0.645923	0.14459	N	0.318328	T	0.69278	0.3093	L	0.54323	1.7	0.09310	N	1	P	0.41673	0.759	B	0.41374	0.355	T	0.61212	-0.7108	10	0.72032	D	0.01	-10.0984	8.746	0.34587	0.2438:0.0:0.7562:0.0	.	187	P23276	KELL_HUMAN	Y	187;168	ENSP00000347409:S187Y;ENSP00000420011:S168Y	ENSP00000347409:S187Y	S	-	2	0	KEL	142365148	0	0.05858	0.133	0.2205	0.928	0.56348	0.173	0.16724	0.768	0.3329	0.65	0.86243	TCC	KEL-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000347671.2	77.016457	KEEP		-	78.640781	0.352941	30	55	---	---	---	---	1	1	302	566	0	1077	32	61	0	74	2	TP
PGM5	5239	broad.mit.edu	37	9	71080089	71080089	+	Missense_Mutation	SNP	G	G	A	rs141668530		GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr9:71080089G>A	ENST00000396396.1	+	7	1353	c.1124G>A	c.(1123-1125)cGt>cAt	p.R375H	PGM5_ENST00000396392.1_Missense_Mutation_p.R375H	NM_021965.3	NP_068800.2	Q15124	PGM5_HUMAN	phosphoglucomutase 5	375		NA		NA	cell adhesion|cellular calcium ion homeostasis|glucose metabolic process	costamere|dystrophin-associated glycoprotein complex|focal adhesion|intercalated disc|internal side of plasma membrane|sarcolemma|spot adherens junction|stress fiber|Z disc	intramolecular transferase activity, phosphotransferases|magnesium ion binding|structural molecule activity			endometrium(5)|kidney(1)|large_intestine(5)|liver(2)|lung(15)|ovary(1)|pancreas(1)|prostate(3)|skin(1)	34						GACTCAGGACGTTGCAATCTG	0.473	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	G	HIS/ARG	1,4405	2.1+/-5.4	0,1,2202	212	193	200	NA	1124	5.9	1	9	dbSNP_134	200	0,8600		0,0,4300	no	missense	PGM5	NM_021965.3	29	0,1,6502	AA,AG,GG	NA	0.0,0.0227,0.0077	probably-damaging	375/568	71080089	1,13005	2203	4300	6503	SO:0001583	missense			ENSG00000154330	HGNC:8908	NM_021965	Approved	uc004agr.3	NA	B1AM46|B4DLQ6|Q5VYV3|Q8N527|Q9UDH4	ENST00000396396.1	37	CCDS6622.2	.	.	.	.	.	.	.	.	.	.	G	21.7	4.193875	0.78902	2.27E-4	0.0	ENSG00000154330	ENST00000396396;ENST00000396392	T;T	0.43688	0.94;0.94	5.87	5.87	0.94306	Alpha-D-phosphohexomutase, alpha/beta/alpha I/II/III (2);Alpha-D-phosphohexomutase, alpha/beta/alpha domain III (1);	0.000000	0.85682	D	0.000000	T	0.73079	0.3541	M	0.92122	3.275	0.80722	D	1	D	0.76494	0.999	D	0.65773	0.938	T	0.78753	-0.2081	10	0.87932	D	0	.	19.3531	0.94398	0.0:0.0:1.0:0.0	.	375	Q15124	PGM5_HUMAN	H	375	ENSP00000379678:R375H;ENSP00000379674:R375H	ENSP00000379674:R375H	R	+	2	0	PGM5	70269909	0.673	0.27539	1	0.80357	0.596	0.36781	3.277	0.51654	2.941	0.99782	0.655	0.94253	CGT	PGM5-001	KNOWN	not_organism_supported|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000052548.2	255.294736	KEEP		+	260.772361	0.344961	89	169	---	---	---	---	1	1	666	752	0	1917	110	206	0	304	2	TP
PRMT8	56341	broad.mit.edu	37	12	3649947	3649947	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr12:3649947G>T	ENST00000382622.3	+	2	641	c.251G>T	c.(250-252)gGg>gTg	p.G84V	PRMT8_ENST00000452611.2_Missense_Mutation_p.G75V|PRMT8_ENST00000261252.4_3'UTR	NM_019854.4	NP_062828.3	Q9NR22	ANM8_HUMAN	protein arginine methyltransferase 8	84		NA		NA	regulation of protein binding	cytoplasm|plasma membrane	histone-arginine N-methyltransferase activity|protein heterodimerization activity|protein homodimerization activity|protein-arginine omega-N asymmetric methyltransferase activity|protein-arginine omega-N monomethyltransferase activity			breast(1)|central_nervous_system(2)|endometrium(1)|kidney(1)|large_intestine(9)|lung(14)|ovary(3)|skin(5)|upper_aerodigestive_tract(1)	37			OV - Ovarian serous cystadenocarcinoma(31;0.0109)|COAD - Colon adenocarcinoma(12;0.0264)			GCCCACTTTGGGATCCACGAG	0.532	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						129	132	131	NA		NA	NA	12		NA											NA				3649947		2203	4300	6503	SO:0001583	missense			ENSG00000111218	HGNC:5188	NM_019854	Approved	uc001qmf.4	NA	B2RDP0|Q8TBJ8	ENST00000382622.3	37	CCDS8521.2	.	.	.	.	.	.	.	.	.	.	G	18.49	3.634374	0.6713	.	.	ENSG00000111218	ENST00000452611;ENST00000382622	T;T	0.24350	1.86;1.86	5.74	5.74	0.90152	.	0.000000	0.85682	D	0.000000	T	0.38453	0.1041	M	0.83118	2.625	0.80722	D	1	P;P	0.43024	0.798;0.696	B;B	0.40375	0.327;0.229	T	0.45425	-0.9262	10	0.87932	D	0	.	17.4274	0.8753	0.0:0.0:1.0:0.0	.	75;84	Q9NR22-2;Q9NR22	.;ANM8_HUMAN	V	75;84	ENSP00000414507:G75V;ENSP00000372067:G84V	ENSP00000372067:G84V	G	+	2	0	PRMT8	3520208	1	0.71417	1	0.80357	0.446	0.32137	9.813	0.99286	2.717	0.92951	0.563	0.77884	GGG	PRMT8-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250297.2	354.112634	KEEP		+	358.032574	0.380952	120	195	---	---	---	---	1	1	762	1313	0	2599	126	206	0	313	2	TP
SIPA1L1	26037	broad.mit.edu	37	14	72055586	72055586	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr14:72055586C>T	ENST00000555818.1	+	2	1345	c.997C>T	c.(997-999)Cac>Tac	p.H333Y	SIPA1L1_ENST00000381232.3_Missense_Mutation_p.H333Y|SIPA1L1_ENST00000358550.2_Missense_Mutation_p.H333Y	NM_015556.1	NP_056371.1	O43166	SI1L1_HUMAN	signal-induced proliferation-associated 1 like 1	333		NA		NA	actin cytoskeleton reorganization|activation of Rap GTPase activity|regulation of dendritic spine morphogenesis	cell junction|cytoplasm|dendritic spine|postsynaptic density|postsynaptic membrane|synaptosome	GTPase activator activity			NS(1)|breast(4)|central_nervous_system(1)|cervix(1)|endometrium(11)|kidney(1)|large_intestine(22)|liver(2)|lung(25)|ovary(3)|prostate(3)|skin(3)|stomach(1)	78				all cancers(60;0.00169)|BRCA - Breast invasive adenocarcinoma(234;0.00912)|OV - Ovarian serous cystadenocarcinoma(108;0.0109)		GTGCTTTGCCCACTATGATGT	0.448	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						69	72	71	NA		NA	NA	14		NA											NA				72055586		2203	4300	6503	SO:0001583	missense				HGNC:20284	NM_015556	Approved	uc001xmr.1	NA	O95321|Q9UDU4|Q9UNU4	ENST00000555818.1	37	CCDS9807.1	.	.	.	.	.	.	.	.	.	.	C	16.04	3.009101	0.54361	.	.	ENSG00000197555	ENST00000381232;ENST00000555818;ENST00000358550	D;D;D	0.86164	-2.08;-2.03;-2.08	6.07	6.07	0.98685	.	0.000000	0.85682	D	0.000000	D	0.94178	0.8132	M	0.80616	2.505	0.80722	D	1	P;D;D	0.89917	0.929;1.0;0.981	P;D;D	0.91635	0.775;0.999;0.954	D	0.93500	0.6843	10	0.59425	D	0.04	-29.4545	20.6593	0.99626	0.0:1.0:0.0:0.0	.	333;333;333	A6H8W6;O43166-2;O43166	.;.;SI1L1_HUMAN	Y	333	ENSP00000370630:H333Y;ENSP00000450832:H333Y;ENSP00000351352:H333Y	ENSP00000351352:H333Y	H	+	1	0	SIPA1L1	71125339	1	0.71417	1	0.80357	0.156	0.22039	7.818	0.86416	2.885	0.99019	0.655	0.94253	CAC	SIPA1L1-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000412806.1	160.829283	KEEP		+	166.830738	0.307692	56	126	---	---	---	---	1	1	234	318	0	908	60	140	0	143	2	TP
SERPINA11	256394	broad.mit.edu	37	14	94914503	94914503	+	Silent	SNP	C	C	T			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr14:94914503C>T	ENST00000334708.3	-	2	673	c.609G>A	c.(607-609)acG>acA	p.T203T	RP11-349I1.2_ENST00000536735.1_RNA	NM_001080451.1	NP_001073920.1	Q86U17	SPA11_HUMAN	serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11	203		NA		NA	regulation of proteolysis	extracellular region	serine-type endopeptidase inhibitor activity			breast(1)|endometrium(2)|kidney(1)|large_intestine(4)|lung(14)|skin(1)|upper_aerodigestive_tract(1)	24				COAD - Colon adenocarcinoma(157;0.211)		GAACCATGAACGTGTCCTGGC	0.473	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						97	98	97	NA		NA	NA	14		NA											NA				94914503		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000186910	HGNC:19193	NM_001080451	Approved	uc001ydd.1	NA	B2RV07	ENST00000334708.3	37	CCDS32149.1												NA	NA	NA								NA	NA	NA																													NA	NA															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		SERPINA11-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000413091.1	217.588309	KEEP		-	220.136249	0.378788	75	123	---	---	---	---	1	1	484	688	0	1431	83	141	0	233	2	TP
RYR3	6263	broad.mit.edu	37	15	34077951	34077951	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr15:34077951G>T	ENST00000389232.4	+	66	9427	c.9357G>T	c.(9355-9357)gaG>gaT	p.E3119D	RYR3_ENST00000415757.3_Missense_Mutation_p.E3119D	NM_001036.3	NP_001027.3	Q15413	RYR3_HUMAN	ryanodine receptor 3	3119		NA		NA	cellular calcium ion homeostasis	integral to membrane	calcium ion binding|receptor activity|ryanodine-sensitive calcium-release channel activity			NS(3)|breast(9)|central_nervous_system(8)|cervix(2)|endometrium(29)|haematopoietic_and_lymphoid_tissue(2)|kidney(18)|large_intestine(55)|lung(148)|ovary(7)|pancreas(1)|prostate(13)|skin(4)|stomach(1)|upper_aerodigestive_tract(8)|urinary_tract(3)	311		all_lung(180;7.18e-09)		all cancers(64;8.95e-12)|GBM - Glioblastoma multiforme(186;0.00109)|BRCA - Breast invasive adenocarcinoma(123;0.0363)		ACCTGGCCGAGTCAGGGGCCC	0.567	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						94	110	105	NA		NA	NA	15		NA											NA				34077951		2179	4291	6470	SO:0001583	missense				HGNC:10485		Approved	uc001zhi.3	NA	O15175|Q15412	ENST00000389232.4	37	CCDS45210.1	.	.	.	.	.	.	.	.	.	.	G	19.48	3.835162	0.71373	.	.	ENSG00000198838	ENST00000389232;ENST00000415757;ENST00000361728	D;D	0.89415	-2.51;-2.51	5.13	3.26	0.37387	.	0.062219	0.64402	D	0.000006	D	0.92021	0.7472	M	0.77616	2.38	0.46678	D	0.999156	D;D	0.67145	0.996;0.991	P;P	0.58928	0.848;0.837	D	0.91787	0.5440	10	0.52906	T	0.07	.	10.6011	0.45367	0.2106:0.0:0.7894:0.0	.	3119;3119	Q15413-2;Q15413	.;RYR3_HUMAN	D	3119	ENSP00000373884:E3119D;ENSP00000399610:E3119D	ENSP00000354735:E3119D	E	+	3	2	RYR3	31865243	1	0.71417	1	0.80357	0.974	0.67602	2.743	0.47442	1.534	0.49203	0.655	0.94253	GAG	RYR3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000417514.1	61.46933	KEEP		+	81.484365	0.167539	32	159	---	---	---	---	1	1	249	1218	5	1798	35	166	0	194	11	TP
BCL2A1	597	broad.mit.edu	37	15	80263133	80263133	+	Missense_Mutation	SNP	G	G	A	rs143571009		GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr15:80263133G>A	ENST00000267953.3	-	1	655	c.329C>T	c.(328-330)cCg>cTg	p.P110L	BCL2A1_ENST00000335661.6_Missense_Mutation_p.P110L	NM_004049.3	NP_004040.1	Q16548	B2LA1_HUMAN	BCL2-related protein A1	110		NA		NA	anti-apoptosis|apoptosis	cytoplasm	protein binding			endometrium(1)|kidney(2)|large_intestine(4)|lung(3)|pancreas(1)|upper_aerodigestive_tract(1)	12						ATCCACATCCGGGGCAATTTG	0.403	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	G	LEU/PRO,LEU/PRO	0,4406		0,0,2203	134	139	137	NA	329,329	-1.9	0	15	dbSNP_134	137	1,8599	1.2+/-3.3	0,1,4299	yes	missense,missense	BCL2A1	NM_001114735.1,NM_004049.3	98,98	0,1,6502	AA,AG,GG	NA	0.0116,0.0,0.0077	benign,benign	110/164,110/176	80263133	1,13005	2203	4300	6503	SO:0001583	missense			ENSG00000140379	HGNC:991	NM_004049	Approved	uc002bfc.4	NA	Q6FGZ4|Q6FH19|Q99524	ENST00000267953.3	37	CCDS10312.1	.	.	.	.	.	.	.	.	.	.	G	3.728	-0.056165	0.07362	0.0	1.16E-4	ENSG00000140379	ENST00000267953;ENST00000335661	T;T	0.18174	2.23;2.23	5.63	-1.91	0.07641	Apoptosis regulator, Bcl2-like (1);Apoptosis regulator, Bcl-2, BH (3);	0.726491	0.12825	N	0.436089	T	0.07413	0.0187	N	0.12502	0.225	0.09310	N	1	B;B	0.13145	0.007;0.007	B;B	0.08055	0.003;0.003	T	0.36286	-0.9754	10	0.25106	T	0.35	-19.5831	6.606	0.22726	0.5593:0.1323:0.3084:0.0	.	110;110	Q86W13;Q16548	.;B2LA1_HUMAN	L	110	ENSP00000267953:P110L;ENSP00000335250:P110L	ENSP00000267953:P110L	P	-	2	0	BCL2A1	78050188	0.68	0.27605	0	0.03702	0.089	0.18198	0.607	0.24209	-0.219	0.10003	-0.345	0.07892	CCG	BCL2A1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000291372.1	87.576819	KEEP		-	122.806221	0.15	45	255	---	---	---	---	1	1	215	868	4	1272	47	274	0	300	10	TP
ALPK3	57538	broad.mit.edu	37	15	85400203	85400203	+	Missense_Mutation	SNP	C	C	A	rs142677464		GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr15:85400203C>A	ENST00000258888.5	+	6	3007	c.2840C>A	c.(2839-2841)gCg>gAg	p.A947E		NM_020778.4	NP_065829.3	Q96L96	ALPK3_HUMAN	alpha-kinase 3	947		NA		NA	heart development	nucleus	ATP binding|protein serine/threonine kinase activity			NS(3)|breast(2)|central_nervous_system(2)|endometrium(12)|kidney(4)|large_intestine(9)|lung(27)|ovary(3)|prostate(5)|skin(8)|stomach(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	81			BRCA - Breast invasive adenocarcinoma(143;0.0587)			CCACCTACAGCGGGTCCTAGA	0.562	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						76	88	84	NA		NA	NA	15		NA											NA				85400203		2203	4299	6502	SO:0001583	missense			ENSG00000136383	HGNC:17574	NM_020778	Approved	uc002ble.3	NA	Q9P2L6	ENST00000258888.5	37	CCDS10333.1	.	.	.	.	.	.	.	.	.	.	C	0.013	-1.634057	0.00806	.	.	ENSG00000136383	ENST00000258888	T	0.56275	0.47	3.94	-1.51	0.08664	.	17.448300	0.00166	N	0.000000	T	0.17152	0.0412	N	0.01048	-1.04	0.09310	N	1	B	0.02656	0.0	B	0.01281	0.0	T	0.36286	-0.9754	10	0.02654	T	1	-8.143	0.927	0.01327	0.3389:0.3178:0.1916:0.1517	.	947	Q96L96	ALPK3_HUMAN	E	947	ENSP00000258888:A947E	ENSP00000258888:A947E	A	+	2	0	ALPK3	83201207	0	0.05858	0	0.03702	0.026	0.11368	-0.392	0.07314	-0.235	0.09767	-1.743	0.00684	GCG	ALPK3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000308997.1	220.406296	KEEP		+	223.096092	0.37234	70	118	---	---	---	---	1	1	400	707	1	1359	75	145	0	248	8	TP
PEX11A	8800	broad.mit.edu	37	15	90226684	90226684	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr15:90226684C>T	ENST00000300056.3	-	3	817	c.668G>A	c.(667-669)gGa>gAa	p.G223E	PEX11A_ENST00000561257.1_Missense_Mutation_p.G192E|PEX11A_ENST00000561224.1_Intron|PEX11A_ENST00000557982.1_Intron|PEX11A_ENST00000559170.1_3'UTR	NM_001271573.1	NP_001258502.1	O75192	PX11A_HUMAN	peroxisomal biogenesis factor 11 alpha	223		NA		NA	cellular lipid metabolic process|peroxisome fission|signal transduction	integral to peroxisomal membrane				endometrium(2)|large_intestine(2)|lung(3)	7	Lung NSC(78;0.0237)|all_lung(78;0.0478)		KIRC - Kidney renal clear cell carcinoma(17;0.0286)|Kidney(142;0.0514)|BRCA - Breast invasive adenocarcinoma(143;0.128)			ACCTCCAAGTCCAATGATGCC	0.483	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						251	251	251	NA		NA	NA	15		NA											NA				90226684		2200	4299	6499	SO:0001583	missense			ENSG00000166821	HGNC:8852	NM_003847	Approved	uc002boi.4	NA		ENST00000300056.3	37	CCDS10354.1	.	.	.	.	.	.	.	.	.	.	C	26.8	4.772264	0.90108	.	.	ENSG00000166821	ENST00000300056	T	0.70399	-0.48	5.22	5.22	0.72569	.	0.000000	0.85682	D	0.000000	D	0.86481	0.5943	M	0.86864	2.845	0.80722	D	1	D	0.89917	1.0	D	0.97110	1.0	D	0.88496	0.3079	10	0.87932	D	0	-13.9724	17.9471	0.89042	0.0:1.0:0.0:0.0	.	223	O75192	PX11A_HUMAN	E	223	ENSP00000300056:G223E	ENSP00000300056:G223E	G	-	2	0	PEX11A	88027688	1	0.71417	0.898	0.35279	0.998	0.95712	7.233	0.78125	2.711	0.92665	0.655	0.94253	GGA	PEX11A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000313420.1	606.718341	KEEP		-	615.350228	0.367384	205	353	---	---	---	---	1	1	379	617	0	1324	217	386	0	537	2	TP
ENO3	2027	broad.mit.edu	37	17	4860277	4860277	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr17:4860277G>A	ENST00000323997.6	+	12	1372	c.1240G>A	c.(1240-1242)Gag>Aag	p.E414K	ENO3_ENST00000519584.1_Missense_Mutation_p.E371K|ENO3_ENST00000518175.1_Missense_Mutation_p.E414K	NM_001976.4|NM_053013.3	NP_001967.3|NP_443739.3	P13929	ENOB_HUMAN	enolase 3 (beta, muscle)	414		NA		NA	gluconeogenesis|glycolysis	phosphopyruvate hydratase complex	magnesium ion binding|phosphopyruvate hydratase activity			cervix(1)|endometrium(1)|large_intestine(4)|lung(8)|ovary(1)	15						TTCTAGGATCGAGGAGGCTCT	0.577	NA	NA		NA			NA	NA			OREG0024110	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						165	164	165	NA		NA	NA	17		NA											NA				4860277		2203	4300	6503	SO:0001583	missense			ENSG00000108515	HGNC:3354		Approved	uc002gab.4	622	B4DUI6|B4DUM6|Q96AE2	ENST00000323997.6	37	CCDS11062.1	.	.	.	.	.	.	.	.	.	.	G	35	5.438508	0.96168	.	.	ENSG00000108515	ENST00000323997;ENST00000519584;ENST00000518175	T;T;T	0.62105	0.05;0.05;0.05	5.93	5.93	0.9592	Enolase, C-terminal (1);	0.000000	0.85682	D	0.000000	D	0.82838	0.5124	M	0.91663	3.23	0.80722	D	1	D;D;D	0.76494	0.999;0.993;0.999	D;P;D	0.63488	0.915;0.778;0.915	D	0.86040	0.1519	10	0.87932	D	0	-26.8125	17.9021	0.88907	0.0:0.0:1.0:0.0	.	414;371;414	P13929;P13929-3;D3DTL2	ENOB_HUMAN;.;.	K	414;371;414	ENSP00000324105:E414K;ENSP00000430636:E371K;ENSP00000431087:E414K	ENSP00000324105:E414K	E	+	1	0	ENO3	4801001	1	0.71417	1	0.80357	0.893	0.52053	5.67	0.68088	2.833	0.97629	0.65	0.86243	GAG	ENO3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000216851.2	297.753437	KEEP		+	298.421025	0.440909	97	123	---	---	---	---	1	1	787	726	6	1789	108	143	0	349	15	TP
GAREM	64762	broad.mit.edu	37	18	29890192	29890192	+	Silent	SNP	G	G	A			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr18:29890192G>A	ENST00000399218.4	-	3	412	c.357C>T	c.(355-357)cgC>cgT	p.R119R	GAREM_ENST00000578619.1_5'UTR|GAREM_ENST00000269209.6_Silent_p.R119R	NM_001242409.1|NM_022751.2	NP_001229338.1|NP_073588.1			GRB2 associated, regulator of MAPK1	NA		NA		NA							NA						TGACGTACACGCGTTCAGGAA	0.413	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						250	213	225	NA		NA	NA	18		NA											NA				29890192		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000141441	HGNC:26136	NM_022751	Approved		NA		ENST00000399218.4	37	CCDS11905.1												NA	NA	NA								NA	NA	NA																													NA	NA															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		GAREM-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000255364.3	286.953723	KEEP		-	291.174137	0.366667	99	171	---	---	---	---	1	1	432	620	6	1439	120	203	0	311	11	TP
PSG7	5676	broad.mit.edu	37	19	43429925	43429925	+	RNA	SNP	C	C	A			GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0152-Tumor-SM-1QUTX	GBM-TCGA-06-0152-Normal-SM-1QUWL	g.chr19:43429925C>A	ENST00000406070.2	-	0	1339				PSG7_ENST00000446844.3_RNA	NM_002783.2	NP_002774.2	Q13046	PSG7_HUMAN	pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene)	NA		NA		NA	female pregnancy	extracellular region					NA		Prostate(69;0.00682)				ATCCACTTACCAGAGACTCTG	0.483	NA	NA		NA			NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						195	197	196	NA		NA	NA	19		NA											NA				43429925		2201	4300	6501					ENSG00000221878	HGNC:9524	NM_001206650	Approved	uc010xwl.2	NA	Q15232	ENST00000406070.2	37													NA	NA	NA								NA	NA	NA																													NA	NA															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		PSG7-001	KNOWN	basic	polymorphic_pseudogene	NA	polymorphic_pseudogene	OTTHUMT00000321431.2	458.362276	KEEP		-	461.968029	0.395778	150	229	---	---	---	---	1	1	376	571	0	1509	175	263	0	427	2	TP
